Johnson & Johnson (JNJ) is 'absolutely' a buy - Cramer
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $275.23 -1.15%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2%
Revenue Growth %: +5.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2%
Revenue Growth %: +5.5%
Join SI Premium – FREE
On CNBC, Jim Cramer said Johnson & Johnson (NYSE: JNJ) is 'absolutely' a buy on earnings, cash flow, the balance sheet, the buyback, and the dividend.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
- SoundHound AI completes LivePerson acquisition, names new CFO
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Jim Cramer, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
